These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6364 related articles for article (PubMed ID: 1300752)

  • 1. [The cellular immunity indices of patients with malignant melanoma using the viral immunomodulator rigvir].
    Glinkina LS; Bruvere RZh; Venskus DR; Garklava RR; Muceniece AJ
    Vopr Onkol; 1992; 38(5):540-7. PubMed ID: 1300752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The humoral immunity indices of patients with malignant skin melanoma using the viral immunomodulator rigvir].
    Glinkina LS; Heisele OG; Garklava RR; Muceniece AJ
    Vopr Onkol; 1992; 38(5):534-40. PubMed ID: 1300751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The reaction of the T-immunity system in patients with malignant skin melanoma and stomach cancer to active nonspecific immunotherapy].
    Glinkina LS; Bruvere RZh
    Vopr Onkol; 1992; 38(6):659-66. PubMed ID: 1300766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of T- and B-cell immunity of regional lymph nodes in patients with skin melanoma and prognosis of the disease].
    Serov AA; Kadagidze ZG
    Vopr Onkol; 1983; 29(12):18-20. PubMed ID: 6607569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some aspects of cell-mediated hypersensitivity in patients with melanoma.
    Moszkowska G; Jassem J; Kondrat W; Kopacz A; Goszczyńska E
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):655-60. PubMed ID: 6970028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin cancer: T-VEC oncolytic viral therapy shows promise in melanoma.
    Killock D
    Nat Rev Clin Oncol; 2015 Aug; 12(8):438. PubMed ID: 26077044
    [No Abstract]   [Full Text] [Related]  

  • 7. Thymosin-inducible lymphocytes in the peripheral blood of patients with malignant melanoma.
    Byrom NA; Campbell MA; Dean AJ; Timlin DM; Volkers C; Bodenham DC; Hobbs JR
    Cancer Treat Rep; 1978 Nov; 62(11):1769-74. PubMed ID: 310343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Disorders of immune system function and their correction in melanomas with regional metastases].
    Labunets IF; Grinevich IuA; Tolstopiatov BA
    Vopr Onkol; 1989; 35(4):416-23. PubMed ID: 2728381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of immunocorrective preparations on the cellular immunity indices of patients with recurrent respiratory diseases].
    Bychkova NH; Marushenko IuV; Son'kin VM
    Lik Sprava; 1999 Jul; (5):46-9. PubMed ID: 10822676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A comparison of the morphofunctional characteristics of the peripheral blood lymphocytes and the immune status of patients with malignant melanoma of the skin].
    Naleskina LA; Ganina KP; Labunets IF; Grinevich IuA; Abramenko VA
    Tsitol Genet; 1996; 30(5):16-22. PubMed ID: 9026985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dynamics of immunologic indices in patients with Kaposi's sarcoma during treatment with the preparation leakadine].
    Gorshkova NI; Samsonov VA; Mazina NM; Parastaev SA
    Vestn Dermatol Venerol; 1989; (9):6-10. PubMed ID: 2609769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cimetidine in malignant melanoma.
    Timm EG; Rozek SL
    DICP; 1989 Sep; 23(9):689-91. PubMed ID: 2800583
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum-mediated blocking of cell-mediated anti-tumor immunity in a melanoma patient: association with BCG immunotherapy and clinical deterioration.
    Levy NL; Mahaley MS; Day ED
    Int J Cancer; 1972 Sep; 10(2):244-8. PubMed ID: 4661092
    [No Abstract]   [Full Text] [Related]  

  • 14. Vaccination and melanoma risk.
    Pfahlberg A; Botev IN; Kölmel KF; Gefeller O
    Int J Cancer; 2002 Nov; 102(1):96-7. PubMed ID: 12353240
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of large doses of dialysable leukocyte extract.
    Khan A; Benjamin C; Antonetti A; Hill JM
    Proc Soc Exp Biol Med; 1980 Oct; 165(1):91-5. PubMed ID: 6968440
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immune reactivity and in vitro effect of levamisole in a group of patients with malignant melanoma].
    Sansoni P; Rossetti A; Valente G; Butturini U
    Boll Ist Sieroter Milan; 1982 Mar; 61(1):51-7. PubMed ID: 6982048
    [No Abstract]   [Full Text] [Related]  

  • 17. [Thymopentin in the treatment of cutaneous melanoma].
    Trevisan G; Agolzer A
    G Ital Dermatol Venereol; 1989 May; 124(5):245-9. PubMed ID: 2695455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-associated dermatomyositis following ipilimumab therapy: a novel immune-mediated adverse event associated with cytotoxic T-lymphocyte antigen 4 blockade.
    Sheik Ali S; Goddard AL; Luke JJ; Donahue H; Todd DJ; Werchniak A; Vleugels RA
    JAMA Dermatol; 2015 Feb; 151(2):195-9. PubMed ID: 25321335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ipilimumab increases activated T cells and enhances humoral immunity in patients with advanced melanoma.
    Weber JS; Hamid O; Chasalow SD; Wu DY; Parker SM; Galbraith S; Gnjatic S; Berman D
    J Immunother; 2012 Jan; 35(1):89-97. PubMed ID: 22130166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The efficacy of taktivin in patients with viral myocarditis and dilated cardiomyopathy].
    Kipshidze NN; Dzhaparidze MM; Dzidziguri LM; Rachvelishvili NB; Dateshidze MN; Demetrashvili MF
    Ter Arkh; 1990; 62(9):116-8. PubMed ID: 2177920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 319.